<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02107183</url>
  </required_header>
  <id_info>
    <org_study_id>Trial120_A</org_study_id>
    <nct_id>NCT02107183</nct_id>
  </id_info>
  <brief_title>Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial</brief_title>
  <acronym>RINO</acronym>
  <official_title>Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether, as compared with the Venturi mask, a
      nasal, high-flow oxygenation device (Optiflow) may reduce the extubation failure rate in
      patients needing oxygen therapy after extubation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study compares the effects of two devices for oxygen therapy, the nasal, high-flow
      (Optiflow, intervention) and the Venturi mask (control), on the outcome of extubation.
      Available data suggest that Optiflow can improve oxygenation and patient's comfort in
      critically ill patients after extubation. The study hypothesis is that Optiflow may reduce
      the extubation failure rate in these patients.

      In the intervention group, patients fulfilling inclusion criteria and not presenting any of
      the exclusion criteria will receive high-flow oxygen through nasal cannula (Optiflow, Fisher
      &amp; Paykel Healthcare Ltd., New Zealand) after extubation. The oxygen concentration (FiO2) will
      be set to reach an oxygenation target similar to control patients (see below), while the gas
      flow rate will be set at 50 L/min.

      In the control group, patients fulfilling inclusion criteria and not presenting any of the
      exclusion criteria will receive oxygen through a standard Venturi mask after extubation. The
      FiO2 will be set to obtain a arterial oxygen saturation (SpO2) between 92% and 98% (or
      between 88% and 95% in hypercapnic patients). Further FiO2 modifications will be performed by
      the attending physicians to meet the oxygenation target.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reintubation</measure>
    <time_frame>within 72 hours after extubation or at ICU discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for Non-Invasive Ventilation</measure>
    <time_frame>at day 28 after inclusion in the study or at ICU discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>at day 28 from the inclusion in the study or at ICU discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>at day 28 from the inclusion in the study or at hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU readmission</measure>
    <time_frame>at day 28 from inclusion in the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>at day 28 from inclusion in the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>at day 28 from inclusion in the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">500</enrollment>
  <condition>Weaning Failure</condition>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Nasal high-flow oxygen therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High-flow, fully humidified oxygen delivered through nasal cannula (Optiflow, Fisher &amp; Paykel Healthcare) after extubation up to ICU discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Venturi mask oxygen therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxygen delivered through standard Venturi mask after extubation up to ICU discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optiflow (Fisher &amp; Paykel Healthcare)</intervention_name>
    <description>This device delivers high-flow oxygen through nasal cannula</description>
    <arm_group_label>Nasal high-flow oxygen therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Venturi mask</intervention_name>
    <description>This device delivers low-flow oxygen at predetermined concentrations</description>
    <arm_group_label>Venturi mask oxygen therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 years

          2. Mechanical ventilation &gt; 24 hours

          3. Signed Informed Consent

          4. Successful spontaneous breathing trial

          5. PaO2/FiO2 ratio ≤ 300 (or SpO2/FiO2 ratio ≤ 300 if SpO2 is lower than 98%) within 30
             min after extubation while breathing through a Venturi mask with a delivered FiO2 of
             31%

        Exclusion Criteria:

          1. Pregnancy

          2. Presence of tracheostomy

          3. Need for immediate post-extubation Non-Invasive Ventilation (&gt;3 consecutive failures
             of the spontaneous breathing trial and/or a PaCO2 &gt; 45 mmHg before the spontaneous
             breathing trial, with a respiratory rate ≥ 25/min)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salvatore Maurizio Maggiore, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University of the Sacred Heart, A. Gemelli Hospital, Rome, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sainte-Marguerite University Hospital</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lapeyronie University Hospital</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Eloi University Hospital</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Pitie-Salpetriere University Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Louis Mourier University Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Louis University Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelismos University Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico University Hospital</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università del Piemonte Orientale, Ospedale della Carità</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic University of the Sacred Heart, A. Gemelli Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Molinette University Hospital</name>
      <address>
        <city>Turin</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università del Piemonte Orientale, Sant'Andrea Hospital</name>
      <address>
        <city>Vercelli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sant Pau University Hospital</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, Montini L, De Gaetano A, Navalesi P, Antonelli M. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014 Aug 1;190(3):282-8. doi: 10.1164/rccm.201402-0364OC.</citation>
    <PMID>25003980</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2014</study_first_submitted>
  <study_first_submitted_qc>April 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2014</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Salvatore Maurizio MAGGIORE, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Oxygen therapy</keyword>
  <keyword>Extubation</keyword>
  <keyword>Weaning</keyword>
  <keyword>Reintubation</keyword>
  <keyword>Acute respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

